PerCP/Cyanine5.5 anti-human TCR α/β Ant
- 产品名称：
- PerCP/Cyanine5.5 anti-human TCR α/β Ant
- 产品类别：
- 抗体
- 产品编号：
- 306723
- 产品应用：
- 306723
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1548 |
1 |
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography and conjugated with PerCP/Cyanine5.5 under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.
- Application Notes
Additional reported applications (for the relevant formats) include: T cell activation. When co-staining with anti-CD3, we recommend using clone UCHT1, since we have confirmed that IP26 does not compete with this clone. ?Other anti-CD3 clones may compete out the binding of IP26. ?
- Additional Product Notes
- BioLegend is in the process of converting the name PerCP/Cy5.5 to PerCP/Cyanine5.5. The dye molecule remains the same, so you should expect the same quality and performance from our PerCP/Cyanine5.5 products. Contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York. (FC)
- Joseph A, et al. 2008. J. Virol. 82:3078. (FC) PubMed
- Pinto JP, et al. 2010. Immunology. 130:217. PubMed
- Product Citations
-
- Zhang H, et al. 2021. Front Immunol. 12:644520. PubMed
- Swadling L, et al. 2020. Cell Rep. 30:687. PubMed
- Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
- Park JA, et al. 2021. Journal for ImmunoTherapy of Cancer. 9(5):. PubMed
- Ye X, et al. 2020. Oncoimmunology. 9:1758602. PubMed
- Keller B, et al. 2016. J Exp Med. 213: 1185 - 1199. PubMed
- Kathamuthu GR, et al. 2021. Front Cell Infect Microbiol. 11:756854. PubMed
- Keck S, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. 12(2):507-545. PubMed
- RRID
- AB_2563001 (BioLegend Cat. No. 306723) AB_2563002 (BioLegend Cat. No. 306724)
